British Columbia Medical Journal (ISSN: 0007-0556; E-ISSN: 0007-0556), published by the British Columbia Medical Association, serves as a key platform for disseminating research and insights in the field of medicine. Established in 1973, this journal encompasses a wide range of topics relevant to general medicine, providing vital contributions to medical practice and education in Canada and beyond. With a Scopus rank of #400/636 and placed in the 37th percentile for general medicine, it holds a Q4 classification in the medicine (miscellaneous) category, reflecting its commitment to addressing emerging topics and challenges within the healthcare landscape. While the journal is not Open Access, it fosters engagement among researchers, practitioners, and students by presenting valuable studies and case reports, enhancing the knowledge base and supporting professional development. As it continues to publish until 2024, the British Columbia Medical Journal remains an essential resource for those seeking to stay informed on the latest developments in medicine.

Revista da Associacao Medica Brasileira, with ISSN 0104-4230 and E-ISSN 1806-9282, is a premier open access journal published by the Associacao Medica Brasileira, located in São Paulo, Brazil. Established in 1976, it has transitioned to an open access model since 1997, making significant contributions to the field of medicine by ensuring that research is freely accessible to a global audience. The journal covers a broad spectrum of medical topics, catering to the diverse interests of researchers, healthcare professionals, and students, and holds a commendable position in the Scopus rankings, being placed in the 63rd percentile of general medicine journals, ranked #230 out of 636. With its commitment to disseminating valuable medical knowledge, Revista da Associacao Medica Brasileira has solidified its role as a vital resource for advancing medical research and practice in Brazil and beyond.

Innere Medizin, published by SPRINGER MEDIZIN VERLAG GmBH, is a prominent journal based in Germany, dedicated to advancing the field of internal medicine. With its ISSN 2731-7080 and E-ISSN 2731-7099, the journal serves as a vital platform for researchers, clinicians, and students focusing on the latest advancements, research developments, and clinical practices in internal medicine. Although categorized in the Q4 quartile for 2023, it is positioned to provide rich content that addresses diverse issues within the field, from chronic illnesses to innovative treatment methodologies. Though currently not an open-access journal, Innere Medizin emphasizes the importance of accessibility in medical research, contributing to impactful discourse within the community. In the competitive landscape of medical publications, it aims to support scholarly communication and enhance knowledge sharing among professionals, making it a significant resource for anyone interested in internal medicine.

Health and Technology, published by SPRINGER HEIDELBERG, is a prominent journal in the interdisciplinary realms of health sciences and technology, with a particular focus on the innovative applications of technology in healthcare settings. With a robust ISSN of 2190-7188 and E-ISSN 2190-7196, the journal has been making significant contributions to the field since its inception in 2011. As of 2023, it is recognized within the Q2 category in Applied Microbiology and Biotechnology, Biomedical Engineering, and Biotechnology, alongside a Q3 ranking in Bioengineering, reflecting its ongoing relevance and impact in these dynamic fields. Its commendable Scopus rankings underscore its commitment to high-quality research, being placed favorably among peers: #86 in Biomedical Engineering and #38 in Applied Microbiology and Biotechnology. Although not currently an Open Access journal, Health and Technology offers a wealth of scholarly content that is crucial for researchers, professionals, and students seeking to explore the intersection of health and technological advancements. With a converged publication timeline extending to 2024, the journal remains a vital resource for those striving to push the boundaries of innovation in health technology.

BIOMARKERS is a distinguished journal published by Taylor & Francis Ltd, focusing on the critical intersection of biochemistry, clinical biochemistry, and health-related toxicology. With a robust history of publication since 1996 and ongoing contributions through to 2024, the journal serves as a vital platform for researchers, professionals, and students keen on exploring innovative biomarker research that spans various domains within the life sciences. The journal is currently ranked in the Q3 quartile in key areas such as Biochemistry and Health, demonstrating its reputation in the scientific community. Although it operates under a subscription model, BIOMARKERS remains an essential resource for advancing knowledge on biomarkers in health and disease, reflecting the latest advancements and methodologies within the rapidly evolving landscape of biomedical research. Researchers looking to publish in this influential journal can expect a rigorous peer-review process aimed at ensuring the dissemination of high-quality scientific inquiry.

SLAS Discovery is a leading academic journal published by Elsevier Science Inc. that serves as a pivotal resource in the fields of Analytical Chemistry, Biochemistry, Biotechnology, and Molecular Medicine. Since its inception in 2017, the journal has become increasingly influential, attaining a Q1 ranking in Analytical Chemistry and notable Q2 rankings in the associated fields as of 2023. With an impressive Scopus rank that places it within the top percentile of its categories, SLAS Discovery highlights groundbreaking research and methodologies impacting drug discovery and development. The journal advocates for open access, ensuring that its curated content is widely available to the scientific community, fostering collaboration and innovation. Researchers, professionals, and students alike will find value in the journal's comprehensive reviews and original research articles that contribute to the advancement of scientific knowledge and applications in life sciences.

Ewha Medical Journal is a distinguished academic publication that endeavors to disseminate innovative research in the field of medicine. Published by the EWHA WOMANS UNIV SCH MEDICINE, this journal serves as a vital platform for the exchange of knowledge and advancements amongst healthcare professionals, researchers, and students. With its ISSN 2234-3180 and E-ISSN 2234-2591, the journal emphasizes rigorous peer review and high-quality research to uphold its commitment to scientific excellence. Though this journal is not open access, it ensures that its articles are accessible to those invested in the medical sciences. Located in the heart of Seoul, South Korea, the journal aims to contribute significantly to the global medical community, addressing a myriad of health-related topics that reflect the pressing issues of contemporary healthcare. The Ewha Medical Journal stands out as an essential resource for those seeking to stay informed about pivotal developments in medicine and related fields.

INTERNAL MEDICINE JOURNAL, published by Wiley, stands as a prominent platform in the field of internal medicine, reflecting the latest advancements and research across a broad spectrum of topics within the discipline. With an ISSN of 1444-0903 and an E-ISSN of 1445-5994, this journal caters to a global audience, primarily situated in the United Kingdom. As a testament to its scholarly impact, the journal holds a Q2 ranking in the Internal Medicine category for 2023, indicating its influence within the field, and ranks #82 out of 167 in Scopus, placing it within the 51st percentile. Covering a convergence of years from 2001 to 2024, the INTERNAL MEDICINE JOURNAL aims to disseminate high-quality research that advances clinical practice, with diverse open access options available for broader readership and engagement. This publication is essential for researchers, healthcare professionals, and students seeking to deepen their understanding of internal medicine and contribute to its ongoing evolution.

Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.

BMC Medicine is a prestigious, peer-reviewed journal published by BMC, specializing in the rapidly evolving field of medicine. Launched in 2003, this journal has consistently operated under an Open Access model, ensuring that groundbreaking research is freely accessible to the global community. With an impressive impact factor, BMC Medicine holds a distinguished Q1 ranking in the field of Medicine (miscellaneous) and ranks #29 out of 636 in General Medicine according to Scopus, placing it in the top 95th percentile of its category. This journal is dedicated to disseminating high-quality research that advances the understanding and practice of medicine, with a comprehensive focus that includes clinical research, public health, and health policy. As part of its commitment to fostering innovation and collaboration in healthcare, BMC Medicine invites researchers, professionals, and students to contribute to this vital platform that addresses the most pressing medical challenges of our time.